Navigation Links
American Oriental Bioengineering Announces September Investor Conferences Participation
Date:9/8/2009

NEW YORK, Sept. 8 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced the Company's participation in the following conferences:

    -- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009
       in Boston, MA.  Management will meet with institutional investors
       throughout the day.

    -- Morgan Stanley Global Healthcare Unplugged Conference, to be held
       September 14-15, 2009 in New York City. Management will meet with
       institutional investors throughout both days.

    -- Merrill Lynch/Bank of America Global Drug, Biotech & Medical Devices
       Conference, to be held September 15-17, 2009 in London. Management will
       present at 1:45pm London Time on September 16, 2009 and meet with
       institutional investors throughout all three days. A live webcast of
       the presentation will be available via the Company's website at
      http://www.bioaobo.com/ .

    -- Susquehanna Financial Group Third Annual Beijing Management Summit, to
       be held September 16-17, 2009 in Beijing, China. Management will speak
       on a panel discussion entitled, "China Pharma/Biotech Panel
       Participants," scheduled from 1:05-2:10pm Beijing Time on September 16,
       2009. In addition, management will also present at 9:45am Beijing Time
       on September 16, 2009 and meet with institutional investors throughout
       both days.

For further details, please contact your respective institutional sales representative.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
2. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
3. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
4. American Oriental Bioengineering Announces Change in Independent Auditor
5. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
6. American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
7. American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
8. American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China
9. American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
10. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
11. New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):